from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2831/echA16

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.000

Cap5-10ug/mL Capreomycintranslation

0.000

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.460

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.445

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.835

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.543

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.562

Clofazimine10-13 ug/mL Clofaziminerespiration

0.142

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.413

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.062

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.225

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.045

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.112

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.201

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.929

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.332

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.553

KCN5-20 ug/mL Potassium cyaniderespiration

0.372

NaN30.2-2 mM Sodium aziderespiration

-0.544

Nigericin50 uM Nigericinrespiration

-0.032

TRC10-150 ug/mL Triclosanrespiration

-0.752

TRZ10-25 ug/mL Thioridazinerespiration

-0.140

Valinomycin0.5-10 uM Valinomycinrespiration

-0.980

ZnSO42 mM ZnSO4respiration

0.545

menadione6-10 ug/mL Menadionerespiration

0.000

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.000

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.000

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.262

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.857

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.689

Cephalexin20-100 ug/mL CephalexincellWall

3.128

Cerulenin0.32-5 ug/mL CerulenincellWall

0.021

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.479

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.035

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.172

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.366

BZA0.12 mg/mL BenzamidearomaticAmides

0.014

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.229

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.320

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

-0.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.227

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.308

UVUV-irradiationDNAdamaging

0.471

ARP41-4 ug/mL Antitubercular compound ARP4?

1.814

Antimycin12.5-50 ug/mL Antimycin A?

-0.542

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.029

PA_110-50 ug/mL Antitubercular compound PA-1?

0.000

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.031

PA8240.2-2 ug/mL PA-824?

0.747

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.405

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.424

Verapamil50 uM Verapamil?

-0.206

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.239

methoxatin10-20 ug/mL Methoxatin?